Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events
Circulation · 16.01.2024 · 149 (3) · 217-226
DOI: 10.1161/circulationaha.123.064296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 16.01.2024. Verfasst von Feitong Wu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (F.W., A.J.V., T.D., C.G.M.). Hauptthemen laut MEDLINE: Atherosclerosis, Cardiovascular Diseases. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Although low-density lipoprotein cholesterol (LDL-C) remains the primary cholesterol target in clinical practice in children and adults, non–high-density lipoprotein cholesterol (non–HDL-C) has been suggested as a more accurate measure of atherosclerotic cardiovascular disease (ASCVD) risk. We examined the associations of childhood non–HDL-C and LDL-C levels with adult ASCVD events and determined whether non–HDL-C has better utility than LDL-C in predicting adult ASCVD events. METHODS: This prospective cohort study included 21 126 participants from the i3C Consortium (International Childhood Cardiovascular Cohorts). Proportional hazards regressions were used to estimate the risk for incident fatal and fatal/nonfatal ASCVD events associated with childhood non–HDL-C and LDL-C levels (age- and sex-specific z scores; concordant/discordant categories defined by guideline-recommended cutoffs), adjusted for sex, Black race, cohort, age at and calendar year of child measurement, body mass index, and systolic blood pressure. Predictive utility was determined by the C index. RESULTS: After an average follow-up of 35 years, 153 fatal ASCVD events occurred in 21 126 participants (mean age at childhood visits, 11.9 years), and 352 fatal/nonfatal ASCVD events occurred in a subset of 11 296 participants who could be evaluated for this outcome. Childhood non–HDL-C and LDL-C levels were each associated with higher risk of fatal and fatal/nonfatal ASCVD events (hazard ratio ranged from 1.27 [95% CI, 1.14–1.41] to 1.35 [95% CI, 1.13–1.60] per unit increase in the risk factor z score). Non–HDL-C had better discriminative utility than LDL-C (difference in C index, 0.0054 [95% CI, 0.0006–0.0102] and 0.0038 [95% CI, 0.0008–0.0068] for fatal and fatal/nonfatal events, respectively). The discordant group with elevated non–HDL-C and normal LDL-C had a higher risk of ASCVD events compared with the concordant group with normal non–HDL-C and LDL-C (fatal events: hazard ratio, 1.90 [95% CI, 0.98–3.70]; fatal/nonfatal events: hazard ratio, 1.94 [95% CI, 1.23–3.06]). CONCLUSIONS: Childhood non–HDL-C and LDL-C levels are associated with ASCVD events in midlife. Non–HDL-C is better than LDL-C in predicting adult ASCVD events, particularly among individuals who had normal LDL-C but elevated non–HDL-C. These findings suggest that both non–HDL-C and LDL-C are useful in identifying children at higher risk of ASCVD events, but non–HDL-C may provide added prognostic information when it is discordantly higher than the corresponding LDL-C and has the practical advantage of being determined without a fasting sample.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (F.W., A.J.V., T.D., C.G.M.).
- Baker Heart and Diabetes Institute, Melbourne, Australia (F.W., C.G.M.).
- Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia (F.W.).
- Department of Medicine, University of Turku, Finland (M.J., J.S.J.V.).
- Division of Medicine, Turku University Hospital, Finland (M.J., J.S.J.V.).
- Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (D.R.J.).
ORCID-Profile: Feitong Wu, Markus Juonala, David R Jacobs, Stephen R Daniels, Mika Kähönen, Jessica G Woo, Alan R Sinaiko, Jorma S A Viikari, Lydia A Bazzano, Trudy L Burns, Julia Steinberger, Elaine M Urbina, Alison J Venn, Olli T Raitakari, Terence Dwyer, Costan G Magnussen
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
- NICHD NIH HHS
- European Research Council
- NIH HHS
- NIGMS NIH HHS
- NIEHS NIH HHS
Zitieren
APA
Wu, F., Juonala, M., Jacobs, D. R., Daniels, S. R., Kähönen, M., Woo, J. G., Sinaiko, A. R., Viikari, J. S. A., Bazzano, L. A., Burns, T. L., Steinberger, J., Urbina, E. M., Venn, A. J., Raitakari, O. T., Dwyer, T., & Magnussen, C. G. (2024). Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events. Circulation, 149(3), 217-226. https://doi.org/10.1161/circulationaha.123.064296
Vancouver
Wu F, Juonala M, Jacobs DR, Daniels SR, Kähönen M, Woo JG, et al. Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events. Circulation. 2024;149(3):217-226. doi:10.1161/circulationaha.123.064296
BibTeX
@article{Wu2024,
author = {Wu, Feitong and Juonala, Markus and Jacobs, David R and Daniels, Stephen R and Kähönen, Mika and Woo, Jessica G and Sinaiko, Alan R and Viikari, Jorma S A and Bazzano, Lydia A and Burns, Trudy L and Steinberger, Julia and Urbina, Elaine M and Venn, Alison J and Raitakari, Olli T and Dwyer, Terence and Magnussen, Costan G},
title = {Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events},
journal = {Circulation},
year = {2024},
volume = {149},
number = {3},
pages = {217--226},
doi = {10.1161/circulationaha.123.064296}
}
EUVIMED